骨科
止血的管理和優化
抗纖溶藥物
Intraoperative pharmacotherapeutic blood management strategies in total knee arthroplasty. (開啟新視窗)
來源: J Knee Surg 2013;26(6):379-85.
檢索: PubMed 23955184
DOI碼: 10.1055/s-0033-1353992
Tranexamic acid in patients undergoing noncardiac surgery. (開啟新視窗)
來源: N Engl J Med. 2022;386(21):1986-97.
檢索: PubMed 35363452
DOI碼: 10.1056/NEJMoa2201171
Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. (開啟新視窗)
來源: Int Orthop 2013;37(3):441-5.
檢索: PubMed 23371424
DOI碼: 10.1007/s00264-013-1787-7
The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. (開啟新視窗)
來源: J Arthroplasty 2015;30(5):776-80.
檢索: PubMed 25534864
DOI碼: 10.1016/j.arth.2014.12.001
Efficacy and Safety of Antifibrinolytic Agents in Reducing Perioperative Blood Loss and Transfusion Requirements in Scoliosis Surgery: A Systematic Review and Meta-Analysis. (開啟新視窗)
來源: PLoS One 2015;10(9):e0137886.
檢索: PubMed 26382761
DOI碼: 10.1371/journal.pone.0137886
Oral is as effective as intravenous tranexamic acid at reducing blood loss in thoracolumbar spinal fusions: a prospective randomized trial. (開啟新視窗)
來源: Spine 2022;47(2):91-8.
檢索: PubMed 34224510
DOI碼: 10.1097/BRS.0000000000004157
重組活化凝血因子VII(rFVIIa)
The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (開啟新視窗)
來源: Spine 2004;29(12):1384-7.
檢索: PubMed 15187645
局部止血藥
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (開啟新視窗)
來源: Ann Surg 2010;251(2):217-28.
檢索: PubMed 20010084
DOI碼: 10.1097/SLA.0b013e3181c3bcca
Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (開啟新視窗)
來源: J Bone Joint Surg Am 2012;94(21):1952-8.
檢索: PubMed 23138237
DOI碼: 10.2106/JBJS.K.00632
The efficacy of bone wax in reduction of perioperative blood loss in total hip arthroplasty via direct anterior approach: a prospective randomized clinical trial. (開啟新視窗)
來源: J Bone Joint Surg Am. 2022;104(20):1805-13.
檢索: PubMed 35984033
DOI碼: 10.2106/JBJS.22.00376
Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (開啟新視窗)
來源: Int Orthop 2019;43(12):2707-14.
檢索: PubMed 30671601
DOI碼: 10.1007/s00264-019-04291-4